BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cao L, Zhu YQ, Wu ZX, Wang GX, Cheng HW. Engineering nanotheranostic strategies for liver cancer. World J Gastrointest Oncol 2021; 13(10): 1213-1228 [PMID: 34721763 DOI: 10.4251/wjgo.v13.i10.1213]
URL: https://www.wjgnet.com/1948-5182/full/v13/i10/1213.htm
Number Citing Articles
1
Mengmei Yin, Kangrui Yuan, Zhengqi Lv, Yiwen Yuan, Xichen Feng, Qinghua Wu. Novel Lanthanum-Based Fluorescent Drug-Loaded Microspheres for Tracing and Inhibition of the HepG2 Cells LineJournal of Macromolecular Science, Part B 2024; : 1 doi: 10.1080/00222348.2024.2316494
2
Long Liu, Qi Wang, Xiaohong Zhao, Yuxi Huang, Yuyi Feng, Yu Zhang, Zheping Fang, Shaowei Li. Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1131892
3
Shuangta Xu, Jianya Cai, Hongwei Cheng, Wei Wang. Sustained release of therapeutic gene by injectable hydrogel for hepatocellular carcinomaInternational Journal of Pharmaceutics: X 2023; 6: 100195 doi: 10.1016/j.ijpx.2023.100195
4
Basil Alawyia, Constantina Constantinou. Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future ProspectsCurrent Treatment Options in Oncology 2023; 24(7): 711 doi: 10.1007/s11864-023-01098-9
5
Alison C. Mackinnon, Dimitar Tonev, Brian Jacoby, Massimo Pinzani, Robert J. Slack. Galectin-3: therapeutic targeting in liver diseaseExpert Opinion on Therapeutic Targets 2023; 27(9): 779 doi: 10.1080/14728222.2023.2258280
6
Mohammad Chehelgerdi, Matin Chehelgerdi, Omer Qutaiba B. Allela, Renzon Daniel Cosme Pecho, Narayanan Jayasankar, Devendra Pratap Rao, Tamilanban Thamaraikani, Manimaran Vasanthan, Patrik Viktor, Natrayan Lakshmaiya, Mohamed J. Saadh, Ayesha Amajd, Mabrouk A. Abo-Zaid, Roxana Yolanda Castillo-Acobo, Ahmed H. Ismail, Ali H. Amin, Reza Akhavan-Sigari. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementationMolecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01865-0